Osteogenesis imperfecta (OI) is a genetic disorder that makes bones extremely fragile, often breaking from minor force or sometimes no apparent cause at all. It affects roughly 1 in 10,000 to 20,000 live births. Sometimes called “brittle bone disease,” OI ranges widely in severity, from people who experience only a handful of fractures in their lifetime to those whose bones break before birth.
Why the Bones Are So Fragile
The underlying problem in most cases of OI is a defect in type I collagen, the protein that acts as the structural scaffolding for bones, skin, tendons, and other connective tissues. Think of collagen as the rebar inside concrete: without it, the structure crumbles under stress. In OI, gene mutations cause the body to either produce too little collagen or produce collagen that is structurally abnormal. Either way, bones end up with reduced density and strength.
Most cases trace back to mutations in the COL1A1 or COL1A2 genes, which carry the instructions for building type I collagen. These mutations are typically inherited in a dominant pattern, meaning a child only needs one copy of the altered gene (from one parent) to develop the condition. In about 25% of cases, though, neither parent carries the mutation. It arises spontaneously in the child.
Rarer forms of OI involve mutations in other genes (including CRTAP, P3H1, FKBP10, WNT1, and others) that don’t make collagen directly but help process or modify it. These forms tend to follow a recessive inheritance pattern, meaning both parents must carry a copy of the mutation.
The Four Hallmark Features
OI is not just a bone disease. Because collagen is found throughout the body, the effects show up in multiple systems. Four features appear most consistently:
- Fragile bones with frequent fractures. This is the defining feature. Fractures can happen from everyday activities like coughing, rolling over in bed, or being picked up.
- Blue or gray tint to the whites of the eyes. The sclera (the white part of the eye) appears bluish because the underlying blood vessels show through abnormally thin tissue.
- Brittle, discolored teeth. The enamel looks normal, but the inner layer of the tooth (dentin) forms incorrectly, making teeth translucent, grayish, or prone to chipping.
- Progressive hearing loss. This often develops in adolescence or early adulthood and is caused by abnormal bone growth in the middle ear.
Beyond these four, many people with OI experience loose joints, easy bruising, short stature, excessive sweating, and hernias. More serious complications can include scoliosis, heart valve problems, and widening of the aorta.
Types and Severity
OI is classified into multiple types, but four account for the vast majority of cases.
Type I is the mildest and most common form, making up roughly half of all cases. People with type I typically have near-normal stature, blue sclera, and fractures that decrease after puberty. Hearing loss may develop in adulthood. A large study tracking patients in England and Wales found no significant excess mortality in this group compared to the general population.
Type II is the most severe. Bones are so fragile that multiple fractures occur before or during birth. Mortality is essentially 100%, either in the womb or shortly after delivery.
Type III is the most severe form compatible with survival. Children are born with fractures, develop progressively bowed limbs, early-onset scoliosis, and profound short stature. Many use wheelchairs. The blue sclera present in infancy often fades by adolescence. Excess mortality is very high in childhood and remains significantly elevated through at least the mid-30s.
Type IV falls between types I and III in severity. Fractures are common, stature is moderately reduced, and the sclera are usually normal or near-normal in color. Mortality is modestly elevated, particularly at younger ages.
Researchers have identified additional types (V through at least XIV), but these are rare and are distinguished mostly by specific genetic causes or unusual features like calcification of the membranes between bones.
How OI Is Diagnosed
In severe cases, OI is obvious at birth or even on prenatal ultrasound, which can reveal shortened, bowed, or fractured limbs. Milder cases may not be suspected until a child has several fractures that seem out of proportion to the injuries that caused them.
Genetic testing is now the standard for confirming a diagnosis. Modern panels use next-generation sequencing to scan 14 or more genes known to cause OI, including the two main collagen genes and the rarer ones involved in collagen processing. These panels have analytical accuracy above 97%. Genetic testing also helps distinguish OI from other conditions that cause fragile bones or frequent fractures in children, which is important because unexplained fractures in young children can sometimes be mistakenly attributed to abuse.
X-rays and bone density scans provide supporting evidence. X-rays may show old healed fractures, thin bone cortex, or bowing of the long bones. Bone density scans consistently show lower-than-normal mineral content.
Medications That Build Bone Density
The most widely used medications for OI are bisphosphonates, drugs that slow bone breakdown and increase bone mineral density. They’re given either as pills or through an IV, depending on the patient’s age and severity. In children with moderate to severe OI, bisphosphonates can measurably increase bone density and reduce bone pain.
Their effect on the thing that matters most, actually preventing fractures, is less clear-cut. A Cochrane review of clinical trials found that while some individual studies reported fracture reductions of 14% to 31%, the pooled data across studies showed no statistically significant difference in fracture rates compared to placebo. This doesn’t mean the medications are useless. Increased bone density and reduced pain are real benefits, and the trials may have been too small or too short to detect a meaningful fracture reduction.
A newer class of treatment targets a protein called sclerostin, which normally puts the brakes on bone formation. By blocking sclerostin, these drugs aim to actively build new bone rather than just slowing its breakdown. A phase 2b trial of one such drug, setrusumab, showed significant increases in bone mineral density and improvements in estimated bone strength at 12 months. However, the primary endpoint of the trial was not met, and there was no significant reduction in fracture rates during the study period. Phase 3 trials are underway.
Surgical Options for Bone Stabilization
For children with moderate to severe OI, surgery often involves placing metal rods inside the long bones of the legs and arms. These rods act as internal splints, reinforcing the bone to prevent fractures and correct bowing. Two types are used: static rods (fixed length) and telescoping rods (designed to lengthen as the child grows).
A long-term study following 52 patients for an average of 13 years found that telescoping rods lasted significantly longer than static ones, 5.8 years versus 4.0 years on average. Bones treated with telescoping rods also required fewer total surgeries over the follow-up period (2.2 versus 3.3). The takeaway for families is that telescoping rods, when available, generally mean fewer return trips to the operating room as a child grows.
Living With OI
Daily life with OI depends enormously on type and severity. People with type I often live fully independent lives with some modifications, like avoiding contact sports and being careful on stairs. They may go years between fractures as adults. People with type III typically need mobility aids, adapted housing, and ongoing physical therapy to maintain muscle strength and joint function.
Fracture frequency tends to decrease after puberty in milder forms, which is welcome news for families navigating repeated breaks during childhood. Physical therapy and low-impact exercise, particularly swimming, help strengthen muscles that support and protect fragile bones. Strong muscles can’t fix the underlying collagen defect, but they reduce the forces that bones have to absorb during everyday movement.
Hearing should be monitored regularly starting in late childhood, since early intervention with hearing aids can prevent the social and educational impacts of gradual hearing loss. Dental care is also important for those with affected teeth, as the abnormal dentin makes teeth more vulnerable to decay and breakage.